Biotech News

SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance

investor.si-bone.com2026-05-06 14:55 EST

Delivered ~ 21% worldwide revenue growth, ~ 5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all   comparisons are to the prior year period) Worldwide revenue of $48.7 million , representing growth of 20.6%   U.S.

Full article